Marianna Mancini, Chief Operating Officer at Viking Therapeutics, Inc. (VKTX), sold 115,322 shares at $32.29 ($3.8M) on 2026-01-05, disclosed to the SEC on 2026-01-05.
Seasonal sale ($3.8M) by Chief Operating Officer — this insider has traded VKTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.29 | 31,961 | $1.0M | 27.1% |
| 2 | $32.29 | 31,961 | $1.0M | 27.1% |
| 3 | $33.37 | 13,600 | $454K | 11.9% |
| 4 | $33.37 | 13,600 | $454K | 11.9% |
| 5 | $34.22 | 10,500 | $359K | 9.4% |
| 6 | $34.22 | 10,500 |
| $359K |
| 9.4% |
| 7 | $35.07 | 1,600 | $56K | 1.5% |
| 8 | $35.07 | 1,600 | $56K | 1.5% |
| Total | $32.97 avg | 115,322 | $3.8M | 100% |
| Filing → |
| VKTX | SELL | 2025-07-03 | $237K | — | Filing → |
| VKTX | SELL | 2025-01-06 | $4.4M | — | Filing → |
| VKTX | SELL | 2024-07-31 | $2.1M | — | Filing → |